Atlas Trials

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Clinical trial NCT07163403 · RECRUITING

Trial details

NCT number
NCT07163403
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Lynch Syndrome
Start date
2025-09-04
Primary completion
2028-09-20
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.